AVEO Oncology
AVEO
#7013
Rank
A$0.74 B
Marketcap
A$21.29
Share price
0.00%
Change (1 day)
144.43%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$75.71 Million a decrease over its 2020 earnings that were of -A$50.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-46.16%
2021 -A$75.71 Million49.9%
2020 -A$50.51 Million-479.04%
2019 A$13.32 M-276.17%
2018 -A$7.57 Million-91.79%
2017 -A$92.14 Million142.38%
2016 -A$38.02 Million78.51%
2015 -A$21.3 Million-71.55%
2014 -A$74.85 Million-50.72%
2013 -A$0.16 Billion-4.88%
2012 -A$0.16 Billion-426.29%
2011 A$48.93 M-159.85%
2010 -A$81.78 Million35.33%
2009 -A$60.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$31.93 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.69 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.70 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.42 B-18,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.40 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.21 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA